EE+ POEM Archive
Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF
Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Mineralocorticoid Receptor Antagonists Improve Outcomes in Patients Younger Than 75 With CHF and Reduced EF." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314237/all/Mineralocorticoid_receptor_antagonists_improve_outcomes_in_patients_younger_than_75_with_CHF_and_reduced_EF.
Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314237/all/Mineralocorticoid_receptor_antagonists_improve_outcomes_in_patients_younger_than_75_with_CHF_and_reduced_EF. Accessed March 26, 2023.
Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314237/all/Mineralocorticoid_receptor_antagonists_improve_outcomes_in_patients_younger_than_75_with_CHF_and_reduced_EF
Mineralocorticoid Receptor Antagonists Improve Outcomes in Patients Younger Than 75 With CHF and Reduced EF [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314237/all/Mineralocorticoid_receptor_antagonists_improve_outcomes_in_patients_younger_than_75_with_CHF_and_reduced_EF.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mineralocorticoid receptor antagonists improve outcomes in patients younger than 75 with CHF and reduced EF
ID - 1314237
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314237/all/Mineralocorticoid_receptor_antagonists_improve_outcomes_in_patients_younger_than_75_with_CHF_and_reduced_EF
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
